| CONTENTS |
| Interview Dr Mark Perkins, Customer Solution Specialist Novozymes Biopharma US |
| Precipitating Improvements in the Formulation & Delivery of Therapeutic Biomolecules & Vaccines Dr Barry Moore, R&D Director XstalBio |
| Company Profile PPD |
| A Nasal Delivery Solution to the Challenges in Biotherapeutic Delivery Dr Shunji Haruta, Executive Officer SNBL |
| Barriers to Biosimilar Insulin Take-up in the US & UK: Insights from the Front line of Diabetes Treatment Sarah Mackinnon, Quantitative Researcher Creative Medical Research (CMR) |
| Company Profile Novozyme BioPharma |